- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
MediciNova Inc (MNOV)
MediciNova Inc stock price live, this page displays NASDAQ MNOV stock exchange data. View the MNOV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the MediciNova Inc real time stock price chart below.
What Is the MediciNova Inc Stock Price Today?
The MediciNova Inc stock price today is 1.600.
What Is the Stock Symbol for MediciNova Inc?
The stock symbol for MediciNova Inc is "MNOV."
What Stock Exchange Does MediciNova Inc Trade On?
MediciNova Inc is listed and trades on the NASDAQ stock exchange.
Is MediciNova Inc a Good Stock to Buy?
Determining whether MediciNova Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MNOV quote. (ISIN: US58468P2065)
What Is the MediciNova Inc Stock Price Today?
The MediciNova Inc stock price today is 1.600.
What Is the Stock Symbol for MediciNova Inc?
The stock symbol for MediciNova Inc is "MNOV."
What Stock Exchange Does MediciNova Inc Trade On?
MediciNova Inc is listed and trades on the NASDAQ stock exchange.
Is MediciNova Inc a Good Stock to Buy?
Determining whether MediciNova Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MNOV quote. (ISIN: US58468P2065)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.600
1.675
52 wk Range
1.130
2.040
Earnings results expected in 11 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.6001.675
52 wk Range
1.1302.040
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MNOV Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
10.000
Upside
+525.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Form 424B5 MediciNova Inc For: 30 December
- Investing.com
- MediciNova receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- MediciNova receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 8K MediciNova Inc For: 30 December
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
MediciNova Inc Company Profile
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2b/3 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID. It is also developing MN-001 (tipelukast), an orally bioavailable small molecule compound in Phase 2 clinical trial to treat fibrotic and other metabolic disorders, including nonalcoholic fatty liver disease and hypertriglycedemia. The company has a license agreement with Kyorin Pharmaceuticals for the development and commercialization of MN-166 and MN-001. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
Compare MNOV to Peers and Sector
Metrics to compare | MNOV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMNOVPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.5x | −1.7x | −0.5x | |
PEG Ratio | 0.39 | 0.02 | 0.00 | |
Price/Book | 1.8x | 1.8x | 2.6x | |
Price / LTM Sales | 304.9x | 20.3x | 3.3x | |
Upside (Analyst Target) | - | 294.1% | 45.7% | |
Fair Value Upside | Unlock | 12.0% | 6.5% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 10.000
(+525.00% Upside)
Earnings
Latest Release
Nov 13, 2025
EPS / Forecast
-0.09 / -0.10
Revenue / Forecast
61.50K / --
People Also Watch
FAQ
What Is the MediciNova (MNOV) Stock Price Today?
The MediciNova stock price today is 1.600
What Stock Exchange Does MediciNova Trade On?
MediciNova is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for MediciNova?
The stock symbol for MediciNova is "MNOV."
What Is the MediciNova Market Cap?
As of today, MediciNova market cap is 78.63M.
What Is MediciNova's Earnings Per Share (TTM)?
The MediciNova EPS (TTM) is -0.24.
When Is the Next MediciNova Earnings Date?
MediciNova will release its next earnings report on Feb 19, 2026.
From a Technical Analysis Perspective, Is MNOV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has MediciNova Stock Split?
MediciNova has split 0 times.
How Many Employees Does MediciNova Have?
MediciNova has 13 employees.
What is the current trading status of MediciNova (MNOV)?
As of Feb 08, 2026, MediciNova (MNOV) is trading at a price of 1.600, with a previous close of 1.620. The stock has fluctuated within a day range of 1.600 to 1.675, while its 52-week range spans from 1.130 to 2.040.
What Is MediciNova (MNOV) Price Target According to Analysts?
The average 12-month price target for MediciNova is USD10.000, with a high estimate of USD11 and a low estimate of USD9. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +525.00% Upside potential.
What Is the MNOV Premarket Price?
MNOV's last pre-market stock price is 1.690. The pre-market share volume is 1,890.000, and the stock has decreased by 0.070, or 4.320%.
What Is the MNOV After Hours Price?
MNOV's last after hours stock price is 1.601, the stock has decreased by 0.001, or 0.080%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.